These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 30316916)

  • 1. Host-based processes as therapeutic targets for Rift Valley fever virus.
    Pinkham C; Ahmed A; Bracci N; Narayanan A; Kehn-Hall K
    Antiviral Res; 2018 Dec; 160():64-78. PubMed ID: 30316916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Phosphatase-1 regulates Rift Valley fever virus replication.
    Baer A; Shafagati N; Benedict A; Ammosova T; Ivanov A; Hakami RM; Terasaki K; Makino S; Nekhai S; Kehn-Hall K
    Antiviral Res; 2016 Mar; 127():79-89. PubMed ID: 26801627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorafenib Impedes Rift Valley Fever Virus Egress by Inhibiting Valosin-Containing Protein Function in the Cellular Secretory Pathway.
    Brahms A; Mudhasani R; Pinkham C; Kota K; Nasar F; Zamani R; Bavari S; Kehn-Hall K
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination Kinase Inhibitor Treatment Suppresses Rift Valley Fever Virus Replication.
    Bell TM; Espina V; Lundberg L; Pinkham C; Brahms A; Carey BD; Lin SC; Dahal B; Woodson C; de la Fuente C; Liotta LA; Bailey CL; Kehn-Hall K
    Viruses; 2018 Apr; 10(4):. PubMed ID: 29652799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin modulation of p70 S6 kinase signaling inhibits Rift Valley fever virus pathogenesis.
    Bell TM; Espina V; Senina S; Woodson C; Brahms A; Carey B; Lin SC; Lundberg L; Pinkham C; Baer A; Mueller C; Chlipala EA; Sharman F; de la Fuente C; Liotta L; Kehn-Hall K
    Antiviral Res; 2017 Jul; 143():162-175. PubMed ID: 28442428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rift Valley fever virus: strategies for maintenance, survival and vertical transmission in mosquitoes.
    Lumley S; Horton DL; Hernandez-Triana LLM; Johnson N; Fooks AR; Hewson R
    J Gen Virol; 2017 May; 98(5):875-887. PubMed ID: 28555542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rift Valley fever virus Gn V5-epitope tagged virus enables identification of UBR4 as a Gn interacting protein that facilitates Rift Valley fever virus production.
    Bracci N; de la Fuente C; Saleem S; Pinkham C; Narayanan A; García-Sastre A; Balaraman V; Richt JA; Wilson W; Kehn-Hall K
    Virology; 2022 Feb; 567():65-76. PubMed ID: 35032865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin inhibits Rift Valley fever virus replication in human cells.
    Narayanan A; Kehn-Hall K; Senina S; Lundberg L; Van Duyne R; Guendel I; Das R; Baer A; Bethel L; Turell M; Hartman AL; Das B; Bailey C; Kashanchi F
    J Biol Chem; 2012 Sep; 287(40):33198-214. PubMed ID: 22847000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Throughput Screening Using a Whole-Cell Virus Replication Reporter Gene Assay to Identify Inhibitory Compounds against Rift Valley Fever Virus Infection.
    Islam MK; Baudin M; Eriksson J; Öberg C; Habjan M; Weber F; Överby AK; Ahlm C; Evander M
    J Biomol Screen; 2016 Apr; 21(4):354-62. PubMed ID: 26762502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Evaluation of Anti-Rift Valley Fever Virus, Antioxidant and Anti-Inflammatory Activity of South African Medicinal Plant Extracts.
    More GK; Makola RT; Prinsloo G
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33572659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and evaluation of antivirals for Rift Valley fever virus.
    Lang Y; Li Y; Jasperson D; Henningson J; Lee J; Ma J; Li Y; Duff M; Liu H; Bai D; McVey S; Richt JA; Ikegami T; Wilson WC; Ma W
    Vet Microbiol; 2019 Mar; 230():110-116. PubMed ID: 30827375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
    Terasaki K; Tercero BR; Makino S
    Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NSs Virulence Factor of Rift Valley Fever Virus Engages the F-Box Proteins FBXW11 and β-TRCP1 To Degrade the Antiviral Protein Kinase PKR.
    Kainulainen M; Lau S; Samuel CE; Hornung V; Weber F
    J Virol; 2016 Jul; 90(13):6140-7. PubMed ID: 27122577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
    Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Genome-Wide RNA Interference Screen Identifies a Role for Wnt/β-Catenin Signaling during Rift Valley Fever Virus Infection.
    Harmon B; Bird SW; Schudel BR; Hatch AV; Rasley A; Negrete OA
    J Virol; 2016 Aug; 90(16):7084-7097. PubMed ID: 27226375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds.
    Garcia S; Crance JM; Billecocq A; Peinnequin A; Jouan A; Bouloy M; Garin D
    J Clin Microbiol; 2001 Dec; 39(12):4456-61. PubMed ID: 11724861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-induced translational arrest through 4EBP1/2-dependent decay of 5'-TOP mRNAs restricts viral infection.
    Hopkins KC; Tartell MA; Herrmann C; Hackett BA; Taschuk F; Panda D; Menghani SV; Sabin LR; Cherry S
    Proc Natl Acad Sci U S A; 2015 Jun; 112(22):E2920-9. PubMed ID: 26038567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying the potential pathways and locations of Rift Valley fever virus entry into the United States.
    Golnar AJ; Kading RC; Hamer GL
    Transbound Emerg Dis; 2018 Feb; 65(1):85-95. PubMed ID: 28191786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome profiling in Rift Valley fever virus infected cells reveals modified transcriptional and alternative splicing programs.
    Havranek KE; White LA; Lanchy JM; Lodmell JS
    PLoS One; 2019; 14(5):e0217497. PubMed ID: 31136639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of adjacent cysteine residues in the NSs protein of Rift Valley fever virus results in loss of virulence in mice.
    Monteiro GER; Jansen van Vuren P; Wichgers Schreur PJ; Odendaal L; Clift SJ; Kortekaas J; Paweska JT
    Virus Res; 2018 Apr; 249():31-44. PubMed ID: 29530722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.